International Journal of Molecular Medical Science, 2024, Vol.14, No.1, 69-79 http://medscipublisher.com/index.php/ijmms 79 Liu G., Li Y., Hu Y., Zong G., Li S., Rimm E., Hu F., Manson J., Rexrode K., Shin H., and Sun Q., 2018, Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus, Journal of the American College of Cardiology, 71(25): 2867-2876. https://doi.org/10.1016/j.jacc.2018.04.027 PMid:29929608 PMCid:PMC6052788 McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D., Hinds D., Pennacchio L., Tybjaerg-hansen A., Folsom A., Boerwinkle E., Hobbs H., and Cohen J., 2007, A common allele on chromosome 9 associated with coronary heart disease, Science, 316(5830): 1488-1491. https://doi.org/10.1126/science.1142447 PMid:17478681 PMCid:PMC2711874 Musunuru K., 2014, Personalized genomes and cardiovascular disease, Cold Spring Harbor Perspectives in Medicine, 5(1): a014068. https://doi.org/10.1101/cshperspect.a014068 PMid:25256177 PMCid:PMC4292073 Oldoni F., Palmen J., Giambartolomei, C., Howard P., Drenos F., Plagnol V., Humphries S., Talmud P., and Smith A., 2016, Post-GWAS methodologies for localisation of functional non-coding variants: ANGPTL3, Atherosclerosis, 246: 193-201. https://doi.org/10.1016/j.atherosclerosis.2015.12.009 PMid:26800306 PMCid:PMC4773290 Pasipoularides A., 2018, Implementing genome-driven personalized cardiology in clinical practice, Journal of molecular and cellular cardiology, 115: 142-157. https://doi.org/10.1016/j.yjmcc.2018.01.008 PMid:29343412 PMCid:PMC5820118 Pérez‐Losada M., Arenas M., Galán J., Bracho M., Hillung J., García-González N., and González-Candelas F., 2020, High-throughput sequencing (HTS) for the analysis of viral populations, Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 80: 104208. https://doi.org/10.1016/j.meegid.2020.104208 PMid:32001386 Rego S., and Snyder M., 2018, High throughput sequencing and assessing disease risk, Cold Spring Harbor perspectives in medicine, 9(1): a026849. https://doi.org/10.1101/cshperspect.a026849 PMid:29959131 PMCid:PMC6314070 Roth G., Mensah G., Johnson C., Addolorato G., Ammirati E., Baddour L., Barengo N., Beaton A., Benjamin E., Benziger C., Bonny A., Brauer M., Brodmann M., Cahill T., Carapetis J., Catapano A., Chugh S., Cooper L., Coresh J., Criqui M., DeCleene N., Eagle K., Emmons-Bell S., Feigin V., Fernandez-Solà J., Fowkes G., Gakidou E., Grundy S., He F., Howard G., Hu F., Inker L., Karthikeyan G., Kassebaum N., Koroshetz W., Lavie C., Lloyd-Jones D., Lu H., Mirijello A., Temesgen A., Mokdad A., Moran A., Muntner P., Narula J., Neal B., Ntsekhe M., Oliveira G., Otto C., Owolabi M., Pratt M., Rajagopalan S., Reitsma M., Ribeiro A., Rigotti N., Rodgers A., Sable C., Shakil S., Sliwa-Hahnle K., Stark B., Sundström J., Timpel P., Tleyjeh I., Valgimigli M., Vos T., Whelton P., Yacoub M., Zuhlke L., Murray C., and Fuster V., 2020, Global burden of cardiovascular diseases and risk factors, 1990-2019, Journal of the American College of Cardiology, 76: 2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010 PMid:33309175 PMCid:PMC7755038 Rysz J., Franczyk B., Rysz-Górzyńska M., and Gluba-Brzózka A., 2020, Pharmacogenomics of hypertension treatment, International Journal of Molecular Sciences, 21(13): 4709. https://doi.org/10.3390/ijms21134709 PMid:32630286 PMCid:PMC7369859 Vrablík M., Dlouhá D., Todorovova V., Stefler D., and Hubacek J., 2021, Genetics of cardiovascular disease: how far are we from personalized CVD risk prediction and management? International Journal of Molecular Sciences, 22(8): 4182. https://doi.org/10.3390/ijms22084182 PMid:33920733 PMCid:PMC8074003 Wang X., Liu X., Zhang W., Zhang H., Paré G., and Liu L., 2018, A15374 genetic variant of human cholesterol ester transfer protein (CETP) raises HDL levels and is associated with increased risk for large vessel and small vessel stroke in Chinese patients, Journal of Hypertension, 36: e83. https://doi.org/10.1097/01.hjh.0000548327.56066.a6 Schnabel R., Baccarelli A., Lin H., Ellinor P., and Benjamin E., 2012, Next steps in cardiovascular disease genomic research--sequencing, epigenetics, and transcriptomics, Clinical chemistry, 58(1): 113-126. https://doi.org/10.1373/clinchem.2011.170423 PMid:22100807 PMCid:PMC3650722 Thanassoulis G., Peloso G., and O’Donnell C., 2013, Genomic medicine for improved prediction and primordial prevention of cardiovascular disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 33(9): 2049-2050. https://doi.org/10.1161/ATVBAHA.113.301814 PMid:23946465 PMCid:PMC4167742
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==